PT  - JOURNAL ARTICLE
AU  - Kaabia, Naoufel M.
AU  - Al Basha, Hanadi
AU  - Bukhari, Dalal A.
AU  - Bouafia, Nabiha
AU  - Al Qahtani, Aeshah N.
AU  - Alshahrani, Ahmad M.
AU  - Aboushanab, Ismail M.
AU  - Al Odayani, Abdulrahman N.
TI  - Epidemiology of <em>Clostridioides difficile</em> infection at a tertiary care facility in Saudi Arabia
AID  - 10.15537/smj.2024.45.2.20230398
DP  - 2024 Feb 01
TA  - Saudi Medical Journal
PG  - 188--193
VI  - 45
IP  - 2
4099  - http://smj.org.sa/content/45/2/188.short
4100  - http://smj.org.sa/content/45/2/188.full
SO  - Saudi Med J2024 Feb 01; 45
AB  - Objectives: To determine the incidence of Clostridioides difficile infection (CDI) and the frequency of known risk factors.Methods: A prospective hospital-based surveillance for CDI, according to the Centers for Disease Control and Prevention criteria, was carried out from July 2019 to March 2022 for all inpatients aged more than one year in Prince Sultan Military Medical City, Riyadh, Saudi Arabia.Results: A total of 139 cases of CDI were identified during the survey among 130 patients admitted in the hospital. Most cases were incident (n=130; 93.5%), and almost three-quarters (n=102; 73.4%) were hospital-onset (HO) CDI, with an incidence rate of 1.62 per 10,000 patient days (PD). The highest rates were noted in intensive care units with an incidence rate of 3 per 10,000 PD and wards for immunocompromised patients with an incidence rate of 2.72 per 10,000 PD. The most prevalent risk factor for CDI was acid-reducing drugs (72.6%). Vancomycin (48%) and ciprofloxacin (25%) were the most frequently prescribed antibiotics for patients with CDI. Clostridioides difficile infection complications were identified in 5.7% of the cases, with a reported 28-day mortality rate of 3.8%.Conclusion: In our hospital, HO-CDI incidence rate is lower than that in high-income countries. National multicenter surveillance is needed to evaluate the actual burden of CDI in Saudi Arabia.